Nuclear Factor Erythroid-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders
Inherited metabolic disorders (IMDs) are rare genetic conditions that affect multiple organs, predominantly the central nervous system. Since treatment for a large number of IMDs is limited, there is an urgent need to find novel therapeutical targets. Nuclear factor erythroid-related factor 2 (Nrf2)...
Enregistré dans:
Auteurs principaux: | Bianca Seminotti, Mateus Grings, Paolo Tucci, Guilhian Leipnitz, Luciano Saso |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/35e0b41a75c444569c68f800a18d11db |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Editorial: Mitochondrial Disorders: Biochemical and Molecular Basis of Disease
par: Guilhian Leipnitz, et autres
Publié: (2021) -
Approach to Neurological Channelopathies and Neurometabolic Disorders in Newborns
par: Inn-Chi Lee
Publié: (2021) -
Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis
par: Shujun Xu, et autres
Publié: (2021) -
Inhibition of miR-448-3p Attenuates Cerebral Ischemic Injury by Upregulating Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)
par: Xu M, et autres
Publié: (2021) -
NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
par: Juan A. Parga, et autres
Publié: (2021)